Thursday’s announcement by the UK Food Standards Agency (FSA) for tightened regulations on CBD products is “welcome” by the industry, a manufacturer said.

Nick Tulloch, chief executive at Zoetic International PLC (LON:ZOE), said the sector had been waiting for more clarity on legal requirements.

“We are supplying customers with a product we say is good for their health, therefore it is important the products are manufactured to a very high standard, and I think what the regulations will do is to ensure those standards are met,” he told Proactive.

READ: Zoetic raises £387,000 to accelerate US plans

But some companies may not have enough resources to be approved by the FSA.

“Some of the smaller CBD sellers will struggle to comply with regulations and, whilst I fell sorry for their businesses, the good news for those of us who can still continue is that we create a much more stable industry with less competition,” Tulloch added.

Zoetic says it has more control on the supply chain as it grows its own hemp which is then used to manufacture products sold under its brand.

FSA’s announcement

The FSA has set 31 March 2021 as an application deadline for CBD products to be granted a licence.

After that date, only those which have applied can stay on the market.

The legislation will be enforced by local authorities to ensure items on the shelves are correctly labelled, safe to eat and do not contain illegal substances.

In the same announcement, the agency advised those who are pregnant, breastfeeding or taking any medication not to consume CBD products.

Healthy adults were recommended a dose of a maximum of 70 milligrams per day, equalling about 28 drops of 5% CBD oil, unless under medical direction.